Edwards Lifesciences Sees Q2 Adj EPS $0.70-$0.76 vs $0.75 Est; Sees Sales $1.660B-$1.740B vs $1.684B Est

Benzinga Newsdesk www.benzinga.com Neutral 70.0%

Neg 0% Neu 70% Pos 0%

Edwards Lifesciences (NYSE:EW) is looking for Q2 Adj EPS of $0.70-$0.76 vs $0.75 analyst estimate. sees sales of $1.660 billion-$1.740 billion vs $1.684 billion analyst estimate.